{"id":"W2897495391","doi":"10.1161/circulationaha.118.035418","title":"Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States","year":2018,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":487,"is_retracted":false,"has_abstract":true,"ca_institutions":"The Quebec Population Health Research Network","funders":"U.S. National Library of Medicine","keywords":"Apixaban; Medicine; Rivaroxaban; Dabigatran; Warfarin; Atrial fibrillation; Internal medicine; Stroke (engine); Dialysis; Hazard ratio; Kidney disease; End stage renal disease; Population; Proportional hazards model; Retrospective cohort study; Intensive care medicine; Disease; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002272222,0.0001242728,0.0001781989,0.0002740022,0.00007088808,0.00005819188,0.00002855818,0.00004353901,0.00003462431],"category_scores_gemma":[0.0004747035,0.00007702207,0.00003355954,0.0005722817,0.00006726696,0.0002825343,0.00001307585,0.00006017632,0.000002943484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000078528,"about_ca_system_score_gemma":0.00003608912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001700946,"about_ca_topic_score_gemma":0.0001828225,"domain_scores_codex":[0.9989945,0.0001147798,0.000224456,0.0001893651,0.0003308129,0.000146082],"domain_scores_gemma":[0.9993203,0.0002026696,0.000131583,0.0001622872,0.0001082399,0.00007493383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008071085,0.000006510152,0.9964353,0.00001348226,0.0000486416,0.000003121168,0.0005053744,0.001737405,0.000001551734,0.0001982086,0.00001967029,0.0002235526],"study_design_scores_gemma":[0.005624276,0.000114999,0.9855297,0.00006869316,0.0001064609,1.226842e-7,0.00007594519,0.007729183,7.188455e-7,0.0000537236,0.0005890917,0.0001071289],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978082,0.000005588869,0.0001097953,0.001027738,0.000045617,0.0009153762,0.00002219666,0.00003339717,0.00003205585],"genre_scores_gemma":[0.9974487,0.000003378273,0.00003911734,0.0002892136,0.0001518806,0.000001341058,0.001984944,0.00001476085,0.0000666194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01090572,"threshold_uncertainty_score":0.3140869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03995022917469284,"score_gpt":0.2866351348459032,"score_spread":0.2466849056712103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}